| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 22, 2005
From the Cooperative Studies Program Coordinating Center (K.T.S.), Hines VA Hospital, Hines, Ill; Midwest Center for Health Services and Policy Research (K.T.S., D.M.H.), Hines VA Hospital, Hines, Ill; Feinberg School of Medicine (K.T.S., L.C., C.L.), Chicago, Ill; VA Information Resource Center (K.T.S., D.M.H.), Hines, Ill; Tucson VA Medical Center (D.A.M.), Tucson, Ariz; University of Arizona (D.A.M.), Tucson, Ariz; Stanford University School of Medicine (M.A.H., P.G.B.), Stanford, Calif; VA Health Economics Resource Center (P.G.B.), Menlo Park, Calif; VA Cooperative Studies Program Coordinating Center (P.G.B.), Palo Alto, Calif; Loyola University Chicago (D.M.H.), Maywood, Ill; and University of Colorado Health Outcomes Program (W.G.H.), Aurora, Col. * To whom correspondence should be addressed. E-mail: Kevin.Stroupe{at}va.gov.
Background--A Department of Veterans Affairs Cooperative Study randomized high-risk patients with medically refractory myocardial ischemia, a group largely excluded from previous trials, to urgent revascularization with either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The present study examined the cost-effectiveness of PCI versus CABG for these high-risk patients. Methods and Results--Of 454 patients at 16 Department of Veterans Affairs medical centers, 445 were available for the economic analysis (218 PCI and 227 CABG patients). Total costs were assessed at 3 and 5 years from the third-party payers perspective, and effectiveness was measured by survival. After 3 years, average total costs were $63 896 for PCI versus $84 364 for CABG patients, a difference of $20 468 (95% confidence interval [CI] $13 918 to $27 569). CIs were estimated by bootstrapping. Survival at 3 years was 0.82 for PCI versus 0.79 for CABG patients (P=0.34). Precision of the cost-effectiveness estimates were assessed by bootstrapping. PCI was less costly and more effective at 3 years in 92.6% of the bootstrap replications. After 5 years, average total costs were $81 790 for PCI versus $100 522 for CABG patients, a difference of $18 732 (95% CI $9873 to $27 831), whereas survival at 5 years was 0.75 for PCI patients versus 0.70 for CABG patients (P=0.21). At 5 years, PCI remained less costly and more effective in 89.4% of the bootstrap replications. Conclusions--PCI was less costly and at least as effective for the urgent revascularization of medically refractory, high-risk patients over 5 years.
Revised on June 23, 2006
Accepted on June 27, 2006
Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous Coronary Intervention for Revascularization of High-Risk Patients
Kevin T. Stroupe PhD*,
Related Article:
Circulation 2006 114: 1225.
This article has been cited by other articles:
![]() |
P. P. Brown, A. D. Kugelmass, D. J. Cohen, M. R. Reynolds, S. D. Culler, A. D. Dee, and A. W. Simon The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States medicare program. Ann. Thorac. Surg., June 1, 2008; 85(6): 1980 - 1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med, November 20, 2007; 147(10): 703 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Bair, J. B. Muhlestein, H. T. May, K. G. Meredith, B. D. Horne, R. R. Pearson, Q. Li, K. R. Jensen, J. L. Anderson, and D. L. Lappe Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease: Results From the Intermountain Heart Registry Circulation, September 11, 2007; 116(11_suppl): I-226 - I-231. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Frye Update in Cardiology Ann Intern Med, August 7, 2007; 147(3): 180 - 186. [Full Text] [PDF] |
||||
![]() |
G. M. Howard-Alpe, J. de Bono, L. Hudsmith, W. P. Orr, P. Foex, and J. W. Sear Coronary artery stents and non-cardiac surgery Br. J. Anaesth., May 1, 2007; 98(5): 560 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Radford Percutaneous Coronary Intervention "Dominates" Coronary Artery Bypass Graft Surgery for High-Risk Patients: Good News for Patients, a Challenge for Healthcare Planners Circulation, September 19, 2006; 114(12): 1229 - 1231. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |